Cardinal Health, a drug wholesaler that also makes gloves and surgical apparel, has been shoring up its future earnings through a series of strategic acquisitions, development of its alternate care business, and promotion of its specialty drug assets. The company has spent $5.7 billion on acquisitions since 2011, including paying $1.94 billion for Johnson & Johnson’s Cordis heart-product business. The deal closed ahead of schedule in late 2015. Along with the Cordis integration and a recent deal with Henry Shein, Cardinal Health will also be focused on its Red Oak venture over the next year. The 10-year split generics buying operation with CVS is a strong earnings booster. The partnerships and purchases are a way for Cardinal Health to snag a greater share of the medical products sold to hospitals, physicians, and ambulatory centers.
News about Cardinal Health
The software giant and four other high-dividend companies look like good buys.
This year's list includes insurers, drug wholesalers, and some household names.
Heritage Group just closed its second fund.
The roster includes big pharmacies, insurers and some names you wouldn't expect.
They're not the ones you'd expect.
Videos about Cardinal Health
But George Barrett thinks a full repeal is unnecessary
Cardinal Health’s CEO George S. Barrett sits down with Fortune's Susie Gharib to discuss how his musical background has helped him listen — and lead — more effectively.
CEO George S. Barrett sits down with Fortune's Susie Gharib to discuss the company's continued investment in China's healthcare infrastructure.
George S. Barrett sits down with Fortune's Susie Gharib and gives his take on the future of the Affordable Care Act.
George S. Barrett sits down with Fortune's Susie Gharib to discuss the company's strategy for growth in a field where every health giant is eagerly snatching up acquisitions.